Multiple Myeloma

Disease State Hub

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

Research Summaries

Multiple Myeloma
Multiple Myeloma
FDA Approves New Immunotherapy for Multiple Myeloma Patients
06/19/2017
The US Food and Drug Administration has approved an immunotherapy with the first CD38-directed antibody to be approved in any country.
06/19/2017
Conference Coverage
Drs Mikhael and Watson
Conference Coverage
Video Recap—Multiple Myeloma Across the Care Continuum
05/13/2016
Brittany Watson, MD, MPH; Joseph Mikhael, MD, MEd, FRCPC
In this video, Brittany Watson, MD, MPH, FAAFP, DABOM and Joseph Mikhael, MD, MEd, FRCPC, FACP, discuss the role of primary care in the early recognition and diagnosis of multiple myeloma, including the...
05/13/2016
FDA Alert
multiple myeloma
FDA Alert
FDA Grants Accelerated Approval to Linvoseltamab-gcpt for Heavily Pretreated Multiple Myeloma
12/10/2015
Kate Young
The FDA has granted accelerated approval to linvoseltamab-gcpt, a BCMA-directed bispecific T-cell engager, offering a new option for patients with heavily pretreated relapsed or refractory multiple myeloma....
12/10/2015
Conference Coverage
woman sitting on the edge of bed
Conference Coverage
Financial Hardship Linked to Delayed Treatment Initiation in Hematologic Malignancies
12/08/2015
Anthony Calabro, MA
A new analysis from Western Washington investigators suggests that adverse financial events at diagnosis may delay treatment initiation for patients with hematologic malignancies, highlighting a potential...
12/08/2015